OverviewChartTechnicalNewsTraderScreen

Ultragenyx Pharmaceutical Inc/  US90400D1081  /

NASDAQ
5/17/2024  10:00:00 PM Chg. -0.7400 Volume Bid12:58:36 AM Ask12:58:36 AM High Low
41.8700USD -1.74% 802,954
Turnover: 24.26 mill.		 41.2200Bid Size: 100 44.5000Ask Size: 400 43.0800 41.7600
GlobeNewswire 5/17 Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 5/15 Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 5/14 Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Me...
GlobeNewswire 5/7 Ultragenyx to Participate at Bank of America’s 2024 Healthcare Conference
GlobeNewswire 5/2 Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 4/30 Ultragenyx Issues 2023 Corporate Responsibility Report, Showcasing Commitment to Improving Equity an...
GlobeNewswire 4/30 Ultragenyx Announces Completion of Enrollment in Phase 3 Orbit and Cosmic Studies Evaluating Setrusu...
GlobeNewswire 4/25 Ultragenyx to Host Conference Call for First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 4/19 Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 4/15 Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatm...
GlobeNewswire 4/15 Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
GlobeNewswire 4/12 Ultragenyx Announces Update to Conference Call Timing to Discuss New Data from GTX-102 in Patients w...
GlobeNewswire 4/12 Ultragenyx Announces Upcoming Data Presentations at American Academy of Neurology (AAN) 2024 Annual ...
GlobeNewswire 4/3 Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Confer...
GlobeNewswire 3/27 Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 3/22 Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 3/5 Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference
GlobeNewswire 2/28 Madrigal Pharmaceuticals Appoints Mardi C. Dier as Chief Financial Officer
GlobeNewswire 2/27 Ultragenyx to Participate at Investor Conferences in March
GlobeNewswire 2/23 Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2/15 Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 2/8 Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2023 Financial Results and Corpo...
GlobeNewswire 2/6 Ultragenyx Announces Data Demonstrating Treatment with UX111 Results in Significant Reduction in Hep...
GlobeNewswire 2/5 Ultragenyx Receives PRIME Designation from European Medicines Agency (EMA) for GTX-102 for the Treat...
GlobeNewswire 1/25 Ultragenyx Announces Completion of Dosing Across Stage 1 Cohorts in Pivotal Phase 1/2/3 Cyprus2+ Stu...